November 16th, 2026Tirzepatide cuts BMI 18.5% in adolescents with obesityIn SURMOUNT-ADOLESCENTS, tirzepatide cut BMI 18.5% at 72 weeks vs a 0.5% rise with placebo in adolescents with obesity.Read more
November 16th, 2026Maternal autoantibodies linked to autism subtype, recurrence riskData presented at NSGC 2026 tie maternal autoantibody combinations to a non-genetic autism subtype with high recurrence risk in later-born siblings.Read more
November 16th, 2026Roflumilast cream 0.05% eases itch, improves QOL in infants with ADCaregivers reported itch, symptom, and QOL gains with roflumilast cream 0.05% in infants with AD; an FDA decision is due February 2027.Read more
November 16th, 2026Etavopivat for sickle cell disease submitted to FDA and EMANovo Nordisk filed etavopivat for SCD in patients aged 12+, backed by phase 3 HIBISCUS data showing a 27% drop in vaso-occlusive crises vs placebo.Read more
November 16th, 2026Semaglutide cuts BMI 13.5% in children aged 6 to 11 with obesityIn STEP Young, semaglutide cut BMI 13.5% at 68 weeks vs a 2.7% rise with placebo in children aged 6 to <12 years with obesity.Read more
November 16th, 2026Is it withdrawal or relapse?In this teaching case, an 18-year-old develops severe anxiety 2 months after stopping long-term fluoxetine because of hyperprolactinemia, raising the question of whether her symptoms reflect antidepressant withdrawal or relapse.Read more
November 13th, 2026Contemporary Pediatrics week in review: November 9-13, 2026Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.Read more
November 13th, 2026Stock epinephrine improves school allergy safety, nurse survey findsSchools without stock epinephrine were over 4 times as likely to lack a device in an allergic emergency, a survey of 349 school nurses found.Read more